Building a Robust, High-Yield Biologics Manufacturing Platform: An Integrated Development Case Study

Nov 2, 2026 1 min read
Building a Robust, High-Yield Biologics Manufacturing Platform:  An Integrated Development Case Study

As biologics processes become increasingly productive, higher upstream titers can create new challenges in downstream processing, product quality, scale-up and manufacturing economics. In this webinar, our Process Development, Analytical Development and MS&T experts will present an integrated development case study, demonstrating how cross-functional collaboration supported the evolution from a conventional process toward a robust, high-yield manufacturing-ready platform.

  • USP intensification and its impact on DSP design and performance
  • Platform analytical strategies supporting process decisions and product quality
  • Scale-up, process robustness and technology transfer considerations
  • Conventional vs. optimized process approaches and key COGS drivers
  • Gain practical insights from an integrated biologics development program
  • See how PD, AD and MS&T expertise can be combined across development and scale-up
  • Learn how to balance yield and productivity with quality, robustness, scalability and manufacturing economics
Author image
Michał Sobala, PhD Senior Director of Process Development

Michał Sobala, PhD, is Senior Director of Process Development at Rezon Bio, where he leads upstream and downstream development for biologics. His work focuses on process intensification, scalable manufacturing platforms and technology transfer, with particular emphasis on intensified fed-batch strategies and integrated USP/DSP development. Michał combines scientific expertise with operational leadership to improve process robustness, increase productivity and reduce manufacturing costs across development and manufacturing

Author image
Kamil Szala Physicochemical Manager

Kamil Szala is a pharmacist and PhD candidate with experience in quality control and analytical research and development. He currently leads the Physicochemical Team within the Analytical Development Department at Rezon Bio. His work focuses on the development, optimization and implementation of physicochemical analytical methods, supporting robust analytical strategies throughout the development process.

Author image
Tomasz Walski, PhD Key Technology Expert

Tomasz Walski, PhD, is a Key Technology Expert at Rezon Bio, where he supports the adaptation of manufacturing capabilities to client-specific process requirements. His expertise includes process scale-up, technology transfer, process validation, and the optimization of biologics manufacturing at commercial scale. Tomasz holds a PhD in Applied Biological Sciences from Ghent University and brings 16 years of experience in protein chemistry and purification.

Share this:
Blog posts

Read more

Ready to get started?

Where innovation meets execution

  1. Whether you’re advancing a novel biologic or planning for commercial scale, Rezon Bio is ready to help you move forward with confidence.
  2. Connect with our team to explore how our expertise, integrated solutions, and dedication can accelerate your success.